1.24
Schlusskurs vom Vortag:
$1.18
Offen:
$1.17
24-Stunden-Volumen:
4.48M
Relative Volume:
1.50
Marktkapitalisierung:
$202.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-111.13M
KGV:
-0.9394
EPS:
-1.32
Netto-Cashflow:
$-91.53M
1W Leistung:
+9.73%
1M Leistung:
+78.85%
6M Leistung:
+181.82%
1J Leistung:
-49.18%
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Firmenname
Tenaya Therapeutics Inc
Sektor
Branche
Telefon
415-865-2066
Adresse
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Vergleichen Sie TNYA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TNYA
Tenaya Therapeutics Inc
|
1.24 | 176.01M | 0 | -111.13M | -91.53M | -1.32 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-06-10 | Eingeleitet | William Blair | Outperform |
2023-11-30 | Eingeleitet | Leerink Partners | Outperform |
2022-06-15 | Eingeleitet | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten
Is Tenaya Therapeutics Inc. a defensive stock2025 Volume Leaders & Community Trade Idea Sharing Platform - khodrobank.com
Historical volatility pattern of Tenaya Therapeutics Inc. visualizedJuly 2025 Fed Impact & Consistent Profit Trading Strategies - Newser
What’s next for Tenaya Therapeutics Inc. stock price2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Regression analysis insights on Tenaya Therapeutics Inc. performancePrice Action & Risk Managed Investment Signals - Newser
Is a relief rally coming for Tenaya Therapeutics Inc. holdersPortfolio Risk Summary & Safe Entry Trade Signal Reports - Newser
Signal strength of Tenaya Therapeutics Inc. stock in tech scanners2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser
Using AI based signals to follow Tenaya Therapeutics Inc.Trade Ideas & High Accuracy Swing Entry Alerts - Newser
What’s the recovery path for long term holders of Tenaya Therapeutics Inc.Weekly Trade Review & Weekly Top Gainers Trade List - Newser
Earnings visualization tools for Tenaya Therapeutics Inc.July 2025 Outlook & Daily Entry Point Alerts - Newser
How moving averages guide Tenaya Therapeutics Inc. tradingFed Meeting & Risk Managed Investment Entry Signals - Newser
Will Tenaya Therapeutics Inc. stock go up soon2025 Price Targets & Daily Market Momentum Tracking - Newser
News impact scoring models applied to Tenaya Therapeutics Inc.Bull Run & Free Expert Approved Momentum Trade Ideas - Newser
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewswire
Heart Disease Biotech Tenaya Therapeutics Featured at Morgan Stanley Global Healthcare Conference 2025 - Stock Titan
Best data tools to analyze Tenaya Therapeutics Inc. stock2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Will Tenaya Therapeutics Inc. rebound enough to break evenWeekly Risk Summary & Daily Technical Forecast Reports - Newser
Layoff Watch: Can Tenaya Therapeutics Inc. reach all time highs this yearBuy Signal & Fast Exit Strategy with Risk Control - khodrobank.com
Long term hold vs stop loss in Tenaya Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - Newser
What’s the analyst consensus on Tenaya Therapeutics Inc.Product Launch & Consistent Profit Alerts - khodrobank.com
Tenaya Therapeutics Inc. stock momentum explained2025 Biggest Moves & AI Forecast for Swing Trade Picks - Newser
How to read the order book for Tenaya Therapeutics Inc.2025 Price Targets & Community Consensus Picks - Newser
What analysts say about Tenaya Therapeutics Inc. stock outlookTrade Signal Summary & Daily Chart Pattern Signal Reports - Newser
Published on: 2025-09-01 18:04:09 - خودرو بانک
What earnings revisions data tells us about Tenaya Therapeutics IncBond Market & Long Hold Capital Preservation Tips - Newser
Volatility clustering patterns for Tenaya Therapeutics Inc.2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - Newser
Tenaya Therapeutics Inc.’s volatility index tracking explained2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Earnings visualization tools for Tenaya Therapeutics IncEarnings Beat & Target Return Focused Stock Picks - Newser
Volume spikes in Tenaya Therapeutics Inc. stock – what they meanQuarterly Market Summary & Risk Controlled Daily Trade Plans - Newser
Published on: 2025-08-31 18:54:47 - Newser
Detecting support and resistance levels for Tenaya Therapeutics Inc.Market Activity Report & Target Return Focused Stock Picks - Newser
Why Tenaya Therapeutics Inc. is moving todayTrade Exit Summary & High Return Trade Opportunity Guides - Newser
Tenaya Therapeutics Presents MyClimb Natural History Study Interim Data at ESC Congress 2025: Largest Noninterventional Study on Pediatric MYBPC3-associated HCM Patients. - AInvest
Tenaya Therapeutics Presents Interim Data from MyClimb™ Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025 - GlobeNewswire
93% of Young Heart Disease Patients Have No Treatment Options: Landmark Tenaya Study of 213 Children - Stock Titan
What earnings revisions data tells us about Tenaya Therapeutics Inc.2025 Valuation Update & AI Based Buy and Sell Signals - Newser
Moving Average Crossover Confirms Uptrend in Tenaya Therapeutics Inc.2025 Bull vs Bear & High Accuracy Trade Signal Alerts - Newser
Finanzdaten der Tenaya Therapeutics Inc-Aktie (TNYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tenaya Therapeutics Inc-Aktie (TNYA) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Tingley Whittemore | Chief Medical Officer |
Aug 18 '25 |
Sale |
1.25 |
5,053 |
6,331 |
172,803 |
Ali Faraz | Chief Executive Officer |
Aug 18 '25 |
Sale |
1.25 |
14,533 |
18,210 |
302,792 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):